PEAK6 Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

PEAK6 Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,756	Closed	-$1.18M	–	4839
2023 Q4	$1.14M	Buy	+12,756	New	+$947K	﹤0.01%	1979
2023 Q2	–	Sell	-44,272	Closed	-$3.7M	–	4806
2023 Q1	$3.37M	Sell	44,272 -78,569	-64%	-$6.52M	0.02%	933
2022 Q4	$10.2M	Buy	+122,841	New	+$9.95M	0.06%	367
2022 Q2	–	Sell	-307,285	Closed	-$23.1M	–	5465
2022 Q1	$27.6M	Buy	+307,285	New	+$28.4M	0.06%	309
2020 Q4	–	Sell	-100,347	Closed	-$12.9M	–	5230
2020 Q3	$11.2M	Buy	+100,347	New	+$11.2M	0.03%	539
2020 Q2	–	Sell	-380,633	Closed	-$37.5M	–	4898
2020 Q1	$10.5M	Buy	+380,633	New	+$33.7M	0.06%	297

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

PEAK6 Investments's XBI Position: Q1 2024 in Review

PEAK6 Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 12,756 shares — an estimated $1.18M sold.

PEAK6 Investments first reported a position in XBI in Q1 2020 and held it in 6 quarters. The position peaked at $27.6M in Q1 2022. 781 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

PEAK6 Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
PEAK6 Investments sold 12,756 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $1.18M.
PEAK6 Investments first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 6 quarters.
PEAK6 Investments's State Street SPDR S&P Biotech ETF position peaked at $27.6M in Q1 2022.
781 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.